NCID 2012 interview with Jean Mossman
February 1, 2013
Cancer Charity Consultant
Patient’s perspective and regulation of treatments
Jean Mossman stresses the importance of the patient’s perspective in cancer care. As the patient receives the treatment, their opinion should be valued; however, the regulatory process between efficacy and safety often creates problems. In some cases, patients with advanced stage cancer will not take safety into consideration as much as efficacy. Very often regulators put too much emphasis on the safety of a drug, which ultimately slows the decision process. Jean Mossman believes that a method needs to be developed that can determine ‘the right timing for the right treatment and the right patient’.
These are interviews with key participants of the National Cancer Institutes Directors Meeting organized annually by the International Prevention Research Institute in Lyon, France. The interviews were produced by eCancer.